waytogo333
09 Nov 2016
Avita Medical Just looking at Avita Medical's latest RNS re trials for regenerative treatment for diabetic foot ulcers. Seems very similar to TRX's product?
theprior
12 Oct 2016
Re: Interims Now that makes sense.Prayer mat doesn'tRegards, TP
waytogo333
12 Oct 2016
Progress Progress.....slower than hoped for, but yes we are still very much in start-up territory. Historically, H2 should see a good uplift in sales as per the RNS.Product range is expanding and you'd like to think that the acceptance of one product into the US market will help with the other that are following on.Interesting to see the section on using the products on sports injuries. There really is a huge market out there.I still have high hopes for this stock and, as has been said previously, 2017 looks to be the year where we get real progress in relation to commercialisation.********** ********** ********** ********** ********** ********** ********** ********OT: 2017 would also appear to be the year for Quadrise (another stock where plenty of patience is required).
Eaglehurst
12 Oct 2016
Re: Interims I've been in here for over a year with the first tranche. I was merely pointing out that the "boast" of sales increased by 150% meant little - the important part of the results were the statements regarding strategic progress.E
theprior
12 Oct 2016
Re: Interims No prayer mat required EH, this is a start up company in its early stage development. No one (with any knowledge of the company) would expect profits so early in the roll out of its products.Not only has TRX got products out there and selling, it's also developing further offerings to the market and, accordingly, the spend on R&D is significant.If your here for a divi you might want to sell and buy LLOY. (They're quite cheap at the moment)If you're looking for exponential growth, stick around, it's coming !!Good luck, TP
Eaglehurst
12 Oct 2016
Re: Interims Sales up 150%. Well, any advance is an advance. However, even at that healthy gross margin, sales 10 times as great would still not see a pre-tax profit. Anyone got a prayer mat?E
Global Nomad
12 Oct 2016
Re: Interims I'll make sure i wrap it in RegenerationPure
theprior
12 Oct 2016
Re: Interims Good luck, GN. Your half toe will soon become a full set of five if TRX get hold of it !! 
))TP
Global Nomad
12 Oct 2016
Re: Interims well i dipped half a toe in this morning. Lack of sp response in either direction shows how far off peoples radar this is and how unsurprising it is to those already invested. If revenues continue to increase and the new products have a similar impact ( having overcome any newcomer inertia) then this should start performer better. Certainly not a star yet and still speculative.
Chicken Lips
12 Oct 2016
Re: Interims Agree too much jam tomorrow still whilst the debt goes south. Been in and out here for some time. Thought this was going to be the big one, but not there yet.The increase in revenue is impressive from where it was but its not going to pay down the debt.
swisspaul
12 Oct 2016
Re: Interims Sorry folks - it don't inspire me - lots of waffle - loss increasing and still a US sales force being paid for what? Not exactly rolling the stuff out of the production line are they?Will hold - but it seems that 2017 is going to be the date when it starts to lift off. Report seems slightly adrift from what the Edison report (paid for) said.
theprior
12 Oct 2016
Re: Interims Great minds.....? Yes, GN, and I for one, enjoy reading your posts.TRX has been making good progress over the last couple of years when it has really broken into the commercial world with a rather unique offering.I've been in for about a year, and during that time the sp has been marking time.I'm hanging on to my shares for now, hoping that the wider world will begin to realise the true value here.Getting a foothold in the US medical system is no mean feat given all the regulatory hurdles a newly has to surmount. Accelerating sales demonstrated in this report mean, to me, that the future is assured.Regards, TP
Global Nomad
12 Oct 2016
Re: Interims Prior, we seem to be sharing some common spaces..I have been out of this for some time but keeping an eye on developments.
theprior
12 Oct 2016
Interims Impressive leap in revenue from last year's period.US sales gaining traction and Europe still to come.Eagerly awaiting TRX's appearance above the parapet ))TP
theprior
27 Sep 2016
A couple of weeks old Found this article on Yahoo Finance : -Tissue Regenix Group plc: DermaPure® - Two Peer Reviewed Clinical Papers Published[link]
